For patients and families in need of life-changing medicines, science can’t wait. Advances in computing power, like AI, are accelerating scientific research and fueling tomorrow's breakthroughs. Watch our EVP of Laboratory Solutions, Randy Stone, and EVP & CIO Michael Wondrasch share some of the ways we tap into cutting-edge technologies to improve and drive efficiency in the drug development process.
Avantor
Biotechnology Research
Radnor Township, Pennsylvania 148,311 followers
We set science in motion to create a better world.
About us
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor. From Fortune ©2023 Fortune Media IP Limited. All rights reserved. Used under license. Fortune and Fortune 500 are registered trademarks of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of, Avantor.
- Website
-
http://avantorsciences.com
External link for Avantor
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Radnor Township, Pennsylvania
- Type
- Public Company
- Founded
- 1904
- Specialties
- Life Science, Advanced Materials, Pharmaceutical Chemicals, Biopharmaceutical Chemicals, BioMaterials, Drug Delivery, Academic Research Chemicals, Laboratory Research Chemicals, Diagnostic Solutions, Environmental Testing Chemicals, Semiconductor Manufacturing Materials, Space-grade Silicones, advanced technology, Biopharma, Healthcare, Education, Government, Applied materials, and Services
Locations
-
Primary
100 Matsonford Rd
Radnor Township, Pennsylvania, US
Employees at Avantor
-
Franklin Davis, Lean Six Sigma Master Black Belt
Multi-Site Vice President of Manufacturing Operations and Engineering
-
Mark Pizov, MBA, MEng
Supply Chain Management | Operations Management | Sales & Operations Planning
-
Kate Tomasini
Senior Recruiting/Talent Acquisition Leader; Ex-Meta, Ex-PwC
-
Katarina Tollin
International Senior Executive in Sourcing, Supply Management, SCM, and Sustainability.
Updates
-
Discover how to operate responsibly across the biopharma value chain in the panel discussion "Building a More Sustainable Biopharma Innovation Ecosystem" including Joydeep Ganguly SVP, Corporate Operations and Chief Sustainability Officer at Gilead Sciences, Mark Steen VP, Sustainability and Climate Initiatives at Corning, Sharon Vidal, Global Head of Corporate Social Responsibility and Sustainability at Illumina and moderated by Avantor’s Head of Sustainability, Rachel Kaufman, MBA. Check out this panel discussion at 3:00 PM in Room 29C at the Biotechnology Innovation Organization Conference. https://lnkd.in/gjnYpbQB #BIO2024
-
Listen to valuable insights from Ger Brophy, Chair of our Scientific Advisory Board, and leaders from EY (Ernst & Young), Alnylam Pharmaceuticals, Epirium, Mnemo Therapeutics, and Business France North America as they discuss learnings on launching innovative therapies in international markets. For those at #BIO2024, attend the “Unlocking Success to Biotech Global Expansion” panel discussion at 4:15 PM today in Room 26B.
-
This June, our PRIDE Network Associate Centric Team (ACT) is celebrating Pride Month by hosting events for our associates, empowering all LGBTQIA+ community members and allies to be their authentic selves. Stefanie Smock, Avantor’s PRIDE Network Americas Lead, shares that “Safe spaces are important to allow associates a chance to hear from members of the communities most affected by the topics discussed and allow us to learn and grow with each other in a safe environment.” We are committed to creating an inclusive environment where authenticity and acceptance are not only embraced but celebrated. Happy Pride Month!
-
Our portfolio is used at every stage of life-changing research, development and production in the biotech ecosystem. For more than 25 years, we have collaborated with the Biotechnology Innovation Organization and we're excited to be at #BIO2024 in San Diego. You can find us in the Bio Business Solution Pavilion at Booth 3027 and hear our Scientific Advisory Board Chair Ger Brophy and Head of Global Sustainability Rachel Kaufman, MBA in next week’s panel discussions.
-
Producing safe, effective viral vectors requires early consideration of scalability. Explore innovations in gene therapy manufacturing like excipient selection and single-use components that can help you scale the production of adeno-associated virus (AAV) efficiently, cost-effectively, and safely to bring therapies to the patients who need them. https://lnkd.in/grmhgMws #CGT #GeneTherapy
-
Advancements in science are increasing the pace of breakthroughs, and we’re helping our customers seize new opportunities and overcome hurdles to bring life-changing innovation to patients. This month marks five years since our initial public offering, and we are proud of the role Avantor has played in accelerating possibilities for customers and excited for the opportunities ahead. Watch the first installment of our Accelerating Possibilities series as our President & CEO, Michael Stubblefield, and SVP, Research & Development, Bioscience Production, Nandu Deorkar, share their perspectives on the future of the industry.
-
Artificial intelligence, paired with advances in genomic sequencing, is changing the pace of innovation in the life sciences industry. Our President & CEO, Michael Stubblefield, joins more than 100 industry leaders to discuss the latest scientific breakthroughs in The New Era of Life Sciences 2024 report published by Newsweek and Investment Reports. https://lnkd.in/g9xxm6xH
-
Supporting the science of today and tomorrow, we continue to build on a legacy of innovation by expanding our J.T.Baker® product portfolio to enable market developments. Discover J.T.Baker’s® 120-year journey here: https://lnkd.in/gZMVt3MU #mAbs #CGT #RecombinantProtein